CorMedix Inc (CRMD)

[axelvento]

nice . bouncer$$$$$$ ; On October 15, 2018, the Company filed a Form S-3 registration statement to register an aggregate of 15,081,634 shares of its common stock issuable upon the exercise of Series B warrants with an exercise price of $1.05 and associated Underwriter warrants with an exercise price of $0.9375, both expiring on August 10, 2022, which were issued in connection with the Company's May 2017 underwritten public offering. The S-3 registration statement replaces a previously effective registration statement that expired earlier this year under which the warrant shares were registered. No additional shares are being registered and no proceeds will be received by the Company except to the extent that warrant holders pay the exercise price to purchase the common shares underlying the warrants.